Company Description
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.
The company offers telehealth platform comprising RexMD, a men’s telehealth brand that provides access to virtual medical treatment for a variety of men’s health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.
It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more.
In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses.
It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels.
The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021.
LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.
| Country | United States |
| Founded | 1994 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 211 |
| CEO | Justin Schreiber |
Contact Details
Address: 236 Fifth Avenue, Suite 400 New York, New York 10001 United States | |
| Phone | 866 351 5907 |
| Website | lifemd.com |
Stock Details
| Ticker Symbol | LFMD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000948320 |
| CUSIP Number | 53216B104 |
| ISIN Number | US53216B1044 |
| Employer ID | 76-0238453 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| Justin Schreiber | Chairman and Chief Executive Officer |
| Marc Benathen | Chief Financial Officer |
| Stefan Galluppi | Chief Innovation Officer |
| Maria E. Stan CPA | Controller and Principal Accounting Officer |
| Dennis Wijnker | Chief Technology Officer |
| Eric H. Yecies | Chief Legal Officer, General Counsel and Secretary |
| Shane Biffar | Chief Compliance Officer and Deputy General Counsel |
| Jessica Friedeman | Chief Marketing Officer |
| Nicholas P. Alvarez | Chief Acquisition Officer and Head of Customer Acquisition |
| Varun Pathak | Chief Software Engineer and Co-Founder of PDF Simpli |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 8, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 7, 2024 | 10-Q | Quarterly Report |
| Oct 31, 2024 | 8-K | Current Report |
| Oct 24, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Aug 13, 2024 | 424B3 | Prospectus |
| Aug 7, 2024 | 10-Q | Quarterly Report |
| Jul 18, 2024 | EFFECT | Notice of Effectiveness |
| Jul 18, 2024 | EFFECT | Notice of Effectiveness |
| Jul 5, 2024 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |